XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | 12 Months Ended
--- | --- | --- | ---
Dec. 31, 2024 | Sep. 30, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Sep. 30, 2023 | Dec. 31, 2024 | Dec. 31, 2023 | Jun. 30, 2024
Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | $ 323 |  |  |  | $ 11,424 |  | $ 1,076 | $ 11,424 |
Accrued restructuring actions balances |  | $ 952 |  |  |  |  | 952 |  |
Restructuring costs | 323 | 753 | $ 21,072 | $ 1,273 | 11,424 |  |  |  |
Cash payments |  |  |  |  |  |  | (1,759) |  | $ (7,682)
Non-cash adjustments |  |  |  |  |  |  |  |  | (25,354)
Adjustments |  |  |  |  |  |  |  |  | 219
Accrued restructuring actions balances | 269 |  | 952 |  |  |  | 269 |  | 952
Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 2,964 |  |  |  |  |  | 13,233 |  |
Accrued restructuring actions balances | 2,663 |  |  |  |  |  |  |  |
Restructuring costs | 2,964 | 10,269 |  |  |  |  |  |  |
Cash payments | (1,546) | (189) |  |  |  |  |  |  |
Non-cash adjustments | (2,424) | (7,417) |  |  |  |  |  |  |
Accrued restructuring actions balances | 1,657 | 2,663 |  |  |  |  | 1,657 |  |
Corporate | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 346 |  |  |  | 1,225 |  | 1,045 | 1,225 |
Corporate | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 189 |  |  |  |  |  | 323 |  |
Diagnostics and Spatial Biology | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments |  |  |  |  | 739 |  |  | 739 |
Diagnostics and Spatial Biology | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | (19) |  |  |  |  |  | 425 |  |
Protein Sciences | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | (23) |  |  |  | 9,460 |  | 31 | 9,460 |
Protein Sciences | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 2,794 |  |  |  |  |  | 12,485 |  |
Cost of Sales | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments |  |  |  |  | 1,174 |  |  | 1,174 |
Cost of Sales | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 2,691 |  |  |  |  |  | 7,589 |  |
Selling, General and Administrative Expenses | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 323 |  |  |  | 10,250 |  | 1,076 | 10,250 |
Selling, General and Administrative Expenses | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 273 |  |  |  |  |  | 5,644 |  |
Employee severance | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | (33) |  |  |  | 4,882 |  | (22) | 4,882 |
Accrued restructuring actions balances |  | 761 |  |  |  |  | 761 |  |
Restructuring costs | $ (33) |  | $ 409 | $ 133 | $ 4,882 |  |  |  |
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] | Cost of Goods and Services Sold, Selling, General and Administrative Expense |  | Cost of Goods and Services Sold, Selling, General and Administrative Expense | Cost of Goods and Services Sold, Selling, General and Administrative Expense | Cost of Goods and Services Sold, Selling, General and Administrative Expense |  |  |  |
Cash payments |  |  |  |  |  |  | (551) |  | (4,882)
Adjustments |  |  |  |  |  |  |  |  | 219
Accrued restructuring actions balances | $ 177 |  | $ 761 |  |  |  | 177 |  | 761
Employee severance | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 205 |  |  |  |  |  | 3,057 |  |
Accrued restructuring actions balances | 2,663 |  |  |  |  |  |  |  |
Restructuring costs | $ 205 | $ 2,852 |  |  |  |  |  |  |
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] | Cost of Goods and Services Sold, Selling, General and Administrative Expense | Cost of Goods and Services Sold, Selling, General and Administrative Expense |  |  |  |  |  |  |
Cash payments | $ (1,211) | $ (189) |  |  |  |  |  |  |
Accrued restructuring actions balances | 1,657 | 2,663 |  |  |  |  | 1,657 |  |
Employee severance | Corporate | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments |  |  |  |  | $ 1,193 |  | (3) | 1,193 |
Employee severance | Corporate | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 185 |  |  |  |  |  | 319 |  |
Employee severance | Diagnostics and Spatial Biology | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments |  |  |  |  | 739 |  |  | 739 |
Employee severance | Diagnostics and Spatial Biology | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | (19) |  |  |  |  |  | 425 |  |
Employee severance | Protein Sciences |  |  |  |  |  |  |  |  |
Accrued restructuring actions balances |  | 0 |  |  |  | $ 897 | 0 | 897 | 897
Cash payments |  |  |  |  |  |  |  |  | (1,118)
Adjustments |  |  |  |  | 132 | $ 89 |  |  |
Accrued restructuring actions balances |  |  | 0 |  |  |  |  |  | 0
Employee severance | Protein Sciences | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | (33) |  |  |  | 2,950 |  | (19) | 2,950 |
Employee severance | Protein Sciences | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 39 |  |  |  |  |  | 2,313 |  |
Asset-related and other | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 356 |  |  |  | 504 |  | 1,098 | 504 |
Accrued restructuring actions balances |  | 190 |  |  |  |  | 190 |  |
Restructuring costs | $ 356 | $ 753 | $ 4,737 | $ 1,140 | $ 504 |  |  |  |
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] | Cost of Goods and Services Sold, Selling, General and Administrative Expense | Cost of Goods and Services Sold, Selling, General and Administrative Expense | Cost of Goods and Services Sold, Selling, General and Administrative Expense | Cost of Goods and Services Sold, Selling, General and Administrative Expense | Cost of Goods and Services Sold, Selling, General and Administrative Expense |  |  |  |
Cash payments |  |  |  |  |  |  | (1,208) |  | (2,800)
Non-cash adjustments |  |  |  |  |  |  |  |  | (3,391)
Accrued restructuring actions balances | $ 92 |  | $ 190 |  |  |  | 92 |  | 190
Asset-related and other | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 2,759 |  |  |  |  |  | 10,176 |  |
Restructuring costs | $ 2,759 | $ 7,417 |  |  |  |  |  |  |
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] | Cost of Goods and Services Sold, Selling, General and Administrative Expense | Cost of Goods and Services Sold, Selling, General and Administrative Expense |  |  |  |  |  |  |
Cash payments | $ (335) |  |  |  |  |  |  |  |
Non-cash adjustments | (2,424) | $ (7,417) |  |  |  |  |  |  |
Asset-related and other | Corporate | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 346 |  |  |  | $ 32 |  | 1,048 | 32 |
Asset-related and other | Corporate | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 4 |  |  |  |  |  | 4 |  |
Asset-related and other | Protein Sciences | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | 10 |  |  |  | 472 |  | 50 | 472 |
Asset-related and other | Protein Sciences | Fiscal Year 2025 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments | $ 2,755 |  |  |  |  |  | $ 10,172 |  |
Impairment of assets held-for-sale | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments |  |  |  |  | 6,038 |  |  | 6,038 |
Restructuring costs |  |  | $ 15,926 |  | $ 6,038 |  |  |  |
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] |  |  | Cost of Goods and Services Sold, Selling, General and Administrative Expense |  | Cost of Goods and Services Sold, Selling, General and Administrative Expense |  |  |  |
Non-cash adjustments |  |  |  |  |  |  |  |  | $ (21,963)
Impairment of assets held-for-sale | Protein Sciences | Fiscal Year 2024 Restructuring Actions |  |  |  |  |  |  |  |  |
Restructuring costs, net of adjustments |  |  |  |  | $ 6,038 |  |  | $ 6,038 |

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan for the current period, net of adjustments. + References No definition available. + Details
Name: | tech_RestructuringCostsNetOfAdjustments
Namespace Prefix: | tech_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17 + Details
Name: | us-gaap_PaymentsForRestructuring
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482047/420-10-45-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1 + Details
Name: | us-gaap_RestructuringCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Indicates line item in statement of income or comprehensive income that includes restructuring charges. + References Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
Namespace Prefix: | us-gaap_
Data Type: | enum2:enumerationSetItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringReserveAccrualAdjustment1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(24)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringReserveNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of decrease in the reserve for full or partial settlement through consideration other than cash. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringReserveSettledWithoutCash2
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_RestructuringPlanAxis=tech_FiscalYear2024RestructuringActionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=tech_FiscalYear2025RestructuringActionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=tech_DiagnosticsAndSpatialBiologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=tech_ProteinSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=tech_AssetRelatedAndOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=tech_ImpairmentOfAssetsHeldForSaleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |